A detailed history of Franklin Resources Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 664,455 shares of CRL stock, worth $130 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
664,455
Previous 665,148 0.1%
Holding current value
$130 Million
Previous $137 Million 4.74%
% of portfolio
0.04%
Previous 0.04%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$187.96 - $245.29 $130,256 - $169,985
-693 Reduced 0.1%
664,455 $131 Million
Q2 2024

Aug 14, 2024

BUY
$206.39 - $268.73 $2.75 Million - $3.59 Million
13,343 Added 2.05%
665,148 $137 Million
Q1 2024

May 13, 2024

SELL
$203.52 - $273.43 $22.6 Million - $30.4 Million
-111,210 Reduced 14.58%
651,805 $177 Million
Q4 2023

Feb 09, 2024

SELL
$164.52 - $238.84 $3.04 Million - $4.42 Million
-18,486 Reduced 2.37%
763,015 $180 Million
Q3 2023

Nov 13, 2023

BUY
$194.44 - $217.61 $10.9 Million - $12.2 Million
56,248 Added 7.76%
781,501 $153 Million
Q2 2023

Aug 11, 2023

SELL
$183.71 - $210.25 $171,585 - $196,373
-934 Reduced 0.13%
725,253 $152 Million
Q1 2023

May 12, 2023

BUY
$191.89 - $259.92 $5.94 Million - $8.05 Million
30,975 Added 4.46%
726,187 $147 Million
Q4 2022

Feb 10, 2023

BUY
$197.11 - $250.07 $9.86 Million - $12.5 Million
50,044 Added 7.76%
695,212 $151 Million
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $40.6 Million - $55.7 Million
222,387 Added 52.6%
645,168 $127 Million
Q2 2022

Aug 11, 2022

BUY
$204.13 - $302.4 $917,768 - $1.36 Million
4,496 Added 1.07%
422,781 $90.5 Million
Q1 2022

May 13, 2022

SELL
$255.51 - $362.11 $19.1 Million - $27 Million
-74,628 Reduced 15.14%
418,285 $119 Million
Q4 2021

Feb 11, 2022

BUY
$351.38 - $448.68 $24.6 Million - $31.5 Million
70,113 Added 16.58%
492,913 $186 Million
Q3 2021

Nov 12, 2021

BUY
$372.64 - $458.3 $15.2 Million - $18.7 Million
40,732 Added 10.66%
422,800 $174 Million
Q2 2021

Aug 13, 2021

BUY
$294.17 - $371.65 $2.67 Million - $3.37 Million
9,073 Added 2.43%
382,068 $141 Million
Q1 2021

May 13, 2021

BUY
$249.67 - $299.48 $3.88 Million - $4.65 Million
15,534 Added 4.35%
372,995 $108 Million
Q4 2020

Feb 10, 2021

BUY
$222.0 - $252.62 $48.7 Million - $55.4 Million
219,383 Added 158.88%
357,461 $89.3 Million
Q3 2020

Nov 12, 2020

BUY
$175.56 - $226.45 $24.2 Million - $31.3 Million
138,078 New
138,078 $31.3 Million
Q2 2020

Aug 13, 2020

SELL
$118.84 - $189.72 $12.1 Million - $19.2 Million
-101,455 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$98.9 - $178.34 $10 Million - $18.1 Million
101,455 New
101,455 $12.8 Million
Q4 2019

Feb 12, 2020

SELL
$126.05 - $152.76 $1.8 Million - $2.18 Million
-14,259 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$125.07 - $143.67 $1.26 Million - $1.45 Million
10,106 Added 243.34%
14,259 $1.89 Million
Q2 2019

Aug 14, 2019

BUY
$123.4 - $148.55 $512,480 - $616,928
4,153 New
4,153 $589,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.